Harrow · 6 days ago
National Director, Hybrid Sales-Rare & Specialty Products
Harrow is a leading North American ophthalmic-focused pharmaceutical company, seeking a National Director of Hybrid Sales for Rare & Specialty Products. The role involves leading a team of Hybrid Eye Sales Representatives to meet or exceed sales objectives while maintaining professional relationships with target physicians and physician groups.
Responsibilities
Implement and execute strategic sales plans to achieve national objectives for ophthalmic pharmaceutical products
Oversee and evaluate sales performance and adjust strategy as needed to meet competitive conditions
Provide direct coaching to Hybrid Sales Representatives and accompany them on periodic field sessions
Monitor customer, market, and competitor activity and update the organization accordingly
Establish and maintain relationships with key opinion leaders and strategic partners
Collaborate with internal partners to develop quarterly variable compensation plans that drive the sales team's profitable revenue objectives
Monitor revenue by account on a weekly basis and help drive account retention and growth
Hire, train, mentor, and develop a highly successful sales and sales management team
Provide detailed and accurate sales forecasting and effectively manage budget and resources
Closely partner with Access, Medical, Marketing, and Data Analytics functions to optimize the business for success
Develop and provide sales updates on a regular basis to the executive team
Effectively utilize the company CRM to monitor reach and frequency across accounts nationwide
Qualification
Required
Bachelor's Degree in Marketing or Business
5+ years of sales management experience, with 2+ years managing remote sales representatives
Ability to travel up to 50% of the time, including overnight stays
Experience with the execution of strategic and targeted business plans around priorities and goals
Proficient with CRM, Word, Excel, and PowerPoint
Possess strong organization and project management skills
Strong and thoughtful communication skills, both verbal and written
Ability to thrive in a fast-paced, ever-changing, highly collaborative work environment
Preferred
MBA preferred
Company
Harrow
Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market.
Funding
Current Stage
Public CompanyTotal Funding
$533.75MKey Investors
Oaktree Capital ManagementSWK Funding
2025-09-08Post Ipo Debt· $250M
2023-07-19Post Ipo Equity· $60M
2023-03-28Post Ipo Debt· $100M
Leadership Team
Recent News
2025-02-12
2025-02-12
Company data provided by crunchbase